Concepedia

Author

Hitomi Saso

The University of Texas MD Anderson Cancer Center

Also Known As

H Saso, H. Saso, Hitomi Saso

38

Publications

1.2K

Citations

9

H-Index

35

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterThe University of Texas at Austin
HS

About

Hitomi Saso is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, tumor biology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

1K

2

Cell Biology

4

4

999

3

Engineering

1

1

32

4

Biology

1

1

32

5

Immunology

1

1

82

Hitomi Saso

×

9

Publications

1.2K

Citations

9

H-Index

YearCitations

IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a

Mickey C.‐T. Hu, Dung‐Fang Lee, Weiya Xia,

Cell

2004

861

TIG1 Promotes the Development and Progression of Inflammatory Breast Cancer through Activation of Axl Kinase

Xiaoping Wang, Hitomi Saso, Takayuki Iwamoto,

Cancer Research

2013

82

MEK Inhibitor Selumetinib (AZD6244; ARRY-142886) Prevents Lung Metastasis in a Triple-Negative Breast Cancer Xenograft Model

Chandra Bartholomeusz, Xuemei Xie, Mary Kathryn Pitner,

Molecular Cancer Therapeutics

2015

68

Safety and Efficacy of Radionuclide Therapy with High-Activity In-111 Pentetreotide in Patients with Progressive Neuroendocrine Tumors

Ebrahim S. Delpassand, Jennifer Sims‐Mourtada, Hitomi Saso,

Cancer Biotherapy and Radiopharmaceuticals

2008

52

Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer

Maria Gagliardi, Mary Kathryn Pitner, Jihyun Park,

Scientific Reports

2020

48

PEA-15 unphosphorylated at both serine 104 and serine 116 inhibits ovarian cancer cell tumorigenicity and progression through blocking β-catenin

J. Jack Lee, Chandra Bartholomeusz, P Liu,

Oncogenesis

2012

42

Double‐stranded RNA: distribution and analysis among isolates of <i>Rhizoctonia solani</i> AG‐2 to ‐13

N. Bharathan, Hitomi Saso, L. Gudipati,

Plant Pathology

2005

32

Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt

Chandra Bartholomeusz, Fumiyuki Yamasaki, Hitomi Saso,

Journal of Cancer

2011

29

MEK1/2 Inhibitor Selumetinib (AZD6244) Inhibits Growth of Ovarian Clear Cell Carcinoma in a PEA-15–Dependent Manner in a Mouse Xenograft Model

Chandra Bartholomeusz, Tetsuro Oishi, Hitomi Saso,

Molecular Cancer Therapeutics

2011

27

Page 1